Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122814514 | 12281451 | 4 | F | 201512 | 20160713 | 20160419 | 20160727 | EXP | US-ACORDA-ACO_122921_2016 | ACORDA | 67.76 | YR | M | Y | 0.00000 | 20160727 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122814514 | 12281451 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 22250 | 10 | MG | TABLET | BID | ||||||
| 122814514 | 12281451 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 0000079809 | 22250 | 10 | MG | TABLET | BID | |||||
| 122814514 | 12281451 | 3 | SS | TECFIDERA | DIMETHYL FUMARATE | 1 | Oral | UNK | U | 0 | |||||||||
| 122814514 | 12281451 | 4 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | U | U | 0 | |||||||||
| 122814514 | 12281451 | 5 | SS | COLCHICINE. | COLCHICINE | 1 | Unknown | U | U | 0 | |||||||||
| 122814514 | 12281451 | 6 | SS | Iron | IRON | 1 | Unknown | U | U | 0 | |||||||||
| 122814514 | 12281451 | 7 | SS | Magnesium | MAGNESIUM | 1 | Unknown | U | U | 0 | |||||||||
| 122814514 | 12281451 | 8 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Unknown | U | U | 0 | |||||||||
| 122814514 | 12281451 | 9 | C | REBIF | INTERFERON BETA-1A | 1 | Unknown | UNK | U | 0 | |||||||||
| 122814514 | 12281451 | 10 | C | COPAXONE | GLATIRAMER ACETATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 122814514 | 12281451 | 11 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 122814514 | 12281451 | 12 | C | Other therapeutic products | UNSPECIFIED INGREDIENT | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122814514 | 12281451 | 1 | Gait disturbance |
| 122814514 | 12281451 | 3 | Multiple sclerosis |
| 122814514 | 12281451 | 4 | Product used for unknown indication |
| 122814514 | 12281451 | 5 | Myocarditis |
| 122814514 | 12281451 | 6 | Anaemia |
| 122814514 | 12281451 | 7 | Product used for unknown indication |
| 122814514 | 12281451 | 8 | Product used for unknown indication |
| 122814514 | 12281451 | 9 | Product used for unknown indication |
| 122814514 | 12281451 | 10 | Product used for unknown indication |
| 122814514 | 12281451 | 11 | Product used for unknown indication |
| 122814514 | 12281451 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122814514 | 12281451 | OT |
| 122814514 | 12281451 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122814514 | 12281451 | Anaemia | |
| 122814514 | 12281451 | Cardiac disorder | |
| 122814514 | 12281451 | Cardiac valve disease | |
| 122814514 | 12281451 | Diarrhoea | |
| 122814514 | 12281451 | Drug interaction | |
| 122814514 | 12281451 | Laboratory test abnormal | |
| 122814514 | 12281451 | Myocardial infarction | |
| 122814514 | 12281451 | Platelet count decreased | |
| 122814514 | 12281451 | Weight decreased | |
| 122814514 | 12281451 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122814514 | 12281451 | 2 | 20150309 | 0 | ||
| 122814514 | 12281451 | 3 | 2016 | 0 | ||
| 122814514 | 12281451 | 9 | 201512 | 0 | ||
| 122814514 | 12281451 | 10 | 20160401 | 0 |